MAPT and Alzheimer disease: Increased pS396-tau burden in the OPL, IPL, GCL, and NFL, accompanied by hypertrophic soma and reduced RBPMS+ RGCs, was observed in MCI and AD patients compared to CN controls (Fig. 3c).